RU2002104525A - METHOD FOR PALLIATIVE TREATMENT OF GENERALIZED CANCER - Google Patents

METHOD FOR PALLIATIVE TREATMENT OF GENERALIZED CANCER

Info

Publication number
RU2002104525A
RU2002104525A RU2002104525/14A RU2002104525A RU2002104525A RU 2002104525 A RU2002104525 A RU 2002104525A RU 2002104525/14 A RU2002104525/14 A RU 2002104525/14A RU 2002104525 A RU2002104525 A RU 2002104525A RU 2002104525 A RU2002104525 A RU 2002104525A
Authority
RU
Russia
Prior art keywords
palliative treatment
generalized
cancer
hydrocartisone
generalized cancer
Prior art date
Application number
RU2002104525/14A
Other languages
Russian (ru)
Other versions
RU2238082C2 (en
Inventor
Олег Владимирович Леонов
Валерий Иванович Широкорад
Игорь Александрович Володин
Original Assignee
Омская государственная медицинская академия
Filing date
Publication date
Application filed by Омская государственная медицинская академия filed Critical Омская государственная медицинская академия
Priority to RU2002104525/14A priority Critical patent/RU2238082C2/en
Priority claimed from RU2002104525/14A external-priority patent/RU2238082C2/en
Publication of RU2002104525A publication Critical patent/RU2002104525A/en
Application granted granted Critical
Publication of RU2238082C2 publication Critical patent/RU2238082C2/en

Links

Claims (2)

1. Способ паллиативного лечения генерализованного рака, включающий внутрилюмбальное введение суспензии гидрокартизона, отличающийся тем, что в межпозвонковый промежуток от Thl2 до L5 в комбинации с гидрокартизоном вводят 2%-ный масляный раствор синэстрола в количестве 80 мг, пятикратно через сутки.1. A method of palliative treatment of generalized cancer, including the intralumbar administration of a suspension of hydrocartisone, characterized in that a 2% oil solution of sinestrol in the amount of 80 mg is administered five times every other day in the intervertebral space from Thl2 to L5 in combination with hydrocartisone. 2. Способ по п.1, отличающийся тем, что гидрокартизон вводят в виде 25%-ной суспензии в количестве 125 мг.2. The method according to claim 1, characterized in that hydrocartisone is administered as a 25% suspension in an amount of 125 mg.
RU2002104525/14A 2002-02-19 2002-02-19 Method of palliative treatment of extended prostate cancer with metastatic backbone damage RU2238082C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002104525/14A RU2238082C2 (en) 2002-02-19 2002-02-19 Method of palliative treatment of extended prostate cancer with metastatic backbone damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002104525/14A RU2238082C2 (en) 2002-02-19 2002-02-19 Method of palliative treatment of extended prostate cancer with metastatic backbone damage

Publications (2)

Publication Number Publication Date
RU2002104525A true RU2002104525A (en) 2003-11-10
RU2238082C2 RU2238082C2 (en) 2004-10-20

Family

ID=33536934

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002104525/14A RU2238082C2 (en) 2002-02-19 2002-02-19 Method of palliative treatment of extended prostate cancer with metastatic backbone damage

Country Status (1)

Country Link
RU (1) RU2238082C2 (en)

Similar Documents

Publication Publication Date Title
YU69902A (en) New piperazine derivatives
MY140679A (en) Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
CO5160365A1 (en) STABILIZED MICROFIBRILLARY CELLULOSE
HK1138265A1 (en) Materials and methods for treating coagulation disorders
MY142846A (en) Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CY1108808T1 (en) MOTORCYCLE UNITS
UA88792C2 (en) Hydroxybenzoate salts of metanicotine compounds
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
EA200401515A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN IN POLYMORPHIC MODIFICATION A
RU2008142261A (en) PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE AND ITS APPLICATION
HK1055117A1 (en) 8,8A-dihydro-indenoÄ11,2-dÜthiazole derivatives, amethod for their production and their use as medi caments.
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
WO2001052855A8 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
NO20021160D0 (en) constituents
WO2005107768A3 (en) Method for improving ventilatory efficiency
AU2003272945A1 (en) Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction
RU2002104525A (en) METHOD FOR PALLIATIVE TREATMENT OF GENERALIZED CANCER
EA200300272A1 (en) NEW HINAZOLIN DERIVATIVES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HK1077303A1 (en) Hexacyclic compounds
WO2005055933A3 (en) Treatment of psoriasis with rosiglitazone
AR053333A1 (en) ORAL AND PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF AROMATIC SOLUBILIZING AGENTS
UA81664C2 (en) Normal;heading 1;heading 2;DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS
ES2138577T3 (en) PROCEDURE OF REALIZATION OF A FILTER FLOOR FOR THE WATER TREATMENT.
ATE513841T1 (en) NEW THIOXYLOSE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE IN THERAPEUTICS
EA200600599A1 (en) CONDENSED PENTACYCLE SIMPLE POLYESTERS